Diagnosis of Unstable Angina Pectoris Has Declined Markedly with the Advent of More Sensitive Troponin Assays

American Journal of Medicine

Volumn 128, Issue 8, 2015, Pages 852-860

  D'Souza, Maria ^a   Sarkisian, Laura ^a   Saaby, Lotte ^a   Poulsen, Tina S ^a   Gerke, Oke ^a   Larsen, Torben B ^b   Diederichsen, Axel C P ^a   Jangaard, Nikolaj ^a   Diederichsen, Søren Z ^a   Hosbond, Susanne ^a   Hove, Jens ^c   Thygesen, Kristian ^d   Mickley, Hans ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute coronary syndrome; Mortality; Myocardial infarction; Troponin; Unstable angina pectoris

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRASUGREL; TROPONIN I; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; TREATMENT RESPONSE; UNSTABLE ANGINA PECTORIS; ANGINA, UNSTABLE; BLOOD; DENMARK; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; IMMUNOASSAY; MORTALITY; MYOCARDIAL INFARCTION; SURVIVAL RATE;

AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; DENMARK; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOASSAY; MALE; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SURVIVAL RATE; TROPONIN I;

EID: 84937814911     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.01.044     Document Type: Article

References (37)

1. E. Braunwald, and D.A. Morrow Unstable angina: is it time for a requiem? Circulation 127 2013 2452 2457
2. E. Braunwald, E.M. Antman, J.W. Beasley, and et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 36 2000 970 1062
3. K. Thygesen, J. Mair, E. Giannitsis, and et al. How to use high-sensitivity cardiac troponins in acute cardiac care Eur Heart J 33 2012 2252 2257
4. L.K. Newby, R.L. Jesse, J.D. Babb, and et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents J Am Coll Cardiol 60 2012 2427 2463
5. H. White, K. Thygesen, J.S. Alpert, and A. Jaffe Universal MI definition update for cardiovascular disease Curr Cardiol Rep 16 2014 492 495
6. K. Thygesen, J.S. Alpert, and H.D. White Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538
7. L. Saaby, T.S. Poulsen, S. Hosbond, and et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction Am J Med 126 2013 789 797
8. L. Saaby, T.S. Poulsen, A.C.P. Diederichsen, and et al. Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort Am J Med 127 2014 295 302
9. F. Van de Werf, J. Bax, A. Betriu, and et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
10. J.P. Bassand, C.W. Hamm, D. Ardissino, and et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
11. M. Schmidt, M. Maeng, C.J. Jakobsen, and et al. Existing data sources for clinical epidemiology: the Western Denmark Heart Registry Clin Epidemiol 2 2010 137 144
12. D. Gaist, H.T. Sorensen, and J. Hallas The Danish prescription registries Dan Med Bull 44 1997 445 448
13. C.B. Pedersen The Danish Civil Registration System Scand J Public Health 39 2011 22 25
14. Q. Lam, M. Black, O. Youdell, H. Spilsbury, and H.G. Schneider Performance evaluation and subsequent clinical experience with the Abbott Automated Architect STAT Troponin-I assay Clin Chem 52 2006 298 300
15. E. Braunwald Unstable angina. A classification Circulation 80 1989 410 414
16. P.G. Steg, R.J. Goldberg, J.M. Gore, and et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE) Am J Cardiol 90 2002 358 363
17. F.T. Chiang, K.G. Shyu, C.J. Wu, and et al. Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry J Formos Med Assoc 113 2014 794 802
18. L. Wallentin, R.C. Becker, A. Budaj, and et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
19. D. Hasdai, S. Behar, L. Wallentin, and et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS) Eur Heart J 23 2002 1190 1201
20. J. Marrugat, M. García, R. Elosua, and et al. Short-term (28 days) prognosis between genders according to the type of coronary event (Q-wave versus non-Q-wave acute myocardial infarction versus unstable angina pectoris) Am J Cardiol 94 2004 1161 1165
21. S.D. Wiviott, E. Braunwald, C.H. McCabe, and et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
22. R. André, V. Bongard, R. Elosua, and et al. International differences in acute coronary syndrome patients' baseline characteristics, clinical management and outcomes in Western Europe: the EURHOBOP study Heart 100 2014 1201 1207
23. C.J. Terkelsen, J.F. Lassen, B.L. Nørgaard, and et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort Eur Heart J 26 2005 18 26
24. D.D. McManus, J. Gore, J. Yarzebski, F. Spencer, D. Lessard, and R.J. Goldberg Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI Am J Med 124 2011 40 47
25. S. Mendis, K. Thygesen, K. Kuulasmaa, and et al. World Health Orginazation definition of myocardial infarction: 2008-09 revision Int J Epidemiol 40 2011 139 146
26. K.M. Nielsen, A. Foldspang, M.L. Larsen, L.U. Gerdes, S. Rasmussen, and O. Faergeman Estimating the incidence of the acute coronary syndrome: data from a Danish cohort of 138 290 persons Eur J Cardiovasc Prev Rehabil 14 2007 608 614
27. K.C. Nikus, M.J. Eskola, V.K. Virtanen, and et al. Mortality of patients with acute coronary syndromes still remains high: a follow-up study of 1188 consecutive patients admitted to a university hospital Ann Med 39 2007 63 71
28. F.S. Apple, and P.O. Collinson Analytical characteristics of high-sensitivity cardiac troponin assays Clin Chem 58 2012 54 61
29. F.S. Apple A new season for cardiac troponin assays: it's time to keep a scorecard Clin Chem 2009 1303 1306
30. E. Aune, J. Hjemsæth, K.A. Fox, K. Endresen, and J.E. Otterstad High mortality rates in conservatively managed patients with acute coronary syndrome Scand Cardiovasc J 40 2006 137 144
31. J.L. Mega, E. Braunwald, S.D. Wiviott, and et al. Rivaroxaban in patients with a recent acute coronary syndrome N Engl J Med 366 2012 9 19
32. B. Vogel, S. Hahne, I. Kozanli, and et al. Influence of updated guidelines on short- and long-term mortality in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) Int J Cardiol 159 2012 198 204
33. N. Brown, M. Melville, D. Gray, and et al. Relevance of clinical trial results in myocardial infarction to medical practice: comparison of four year outcome in participants of a thrombolytic trial, patients receiving routine thrombolysis, and those deemed ineligible for thrombolysis Heart 81 1999 598 602
34. M.C. Bahit, C.P. Cannon, E.M. Antman, and et al. Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry Am Heart J 145 2003 109 117
35. E. Björklund, B. Lindahl, U. Stenestrand, and et al. Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial Am Heart J 148 2004 566 573
36. F.K. Korley, and A.S. Jaffe Preparing tke United States for high-sensitivity cardiac troponin assays J Am Coll Cardiol 61 2013 1753 1758
37. M.J. Lipinski, N.C. Baker, R.O. Escarcega, and et al. Comparison of conventional and high-sensitivity troponin in patients with chest pain: a collaborative meta-analysis Am Heart J 169 2014 6 16.e6